EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Indicator Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ Takeda Pharmaceutical +
@ 持田製薬 +
@ NIPPON KAYAKU +
@ SAWAI PHARMACEUTICAL +
@ Sekisui Chemical +
@ ダイセル +
@ MANDOM +
@ キッセイ薬品工業 +
@ TSUMURA & CO. +
@ 長谷川香料 +
@ Fuso Pharmaceutical Industries +
@ 千寿製薬 +
@ Kuraray +
@ Hitachi Chemical +
@ Aica Kogyo +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-03 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
ROHM
graph
日本アビオニクス
graph
日本アビオニクス
graph
日本アビオニクス
graph
NIPPON COKE & ENGINEERING
graph

Financial Indicator Details: ROHTO PHARMACEUTICAL (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Indicator data

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability2009-03-312010-03-312011-03-312012-03-312013-03-31
Net profit margin
(Industry Average)
5.55%
(-12.05%)
6.84%
(-0.50%)
6.89%
(1.53%)
6.80%
(-1.67%)
6.26%
(3.05%)
C/F margin
(Industry Average)
6.65%
(-3.31%)
13.30%
(8.51%)
11.19%
(7.04%)
8.63%
(6.35%)
12.93%
(8.25%)
ROA
(Industry Average)
5.47%
(0.52%)
6.43%
(1.04%)
6.29%
(2.07%)
6.01%
(0.06%)
5.36%
(2.71%)
ROE
(Industry Average)
9.14%
(-1.43%)
10.54%
(0.03%)
10.22%
(2.96%)
9.78%
(4.68%)
8.62%
(4.57%)
Growth2009-03-312010-03-312011-03-312012-03-312013-03-31
Equity growth
(Industry Average)
-
(-)
9.76%
(5.01%)
5.75%
(2.61%)
7.33%
(-0.40%)
12.13%
(8.16%)
Sales growth
(Industry Average)
-
(-)
2.54%
(-2.67%)
1.80%
(5.36%)
4.17%
(1.07%)
7.36%
(2.24%)
Net profit growth
(Industry Average)
-
(-)
26.53%
(203.46%)
2.54%
(63.25%)
2.73%
(3.89%)
-1.18%
(90.38%)
Operating C/F growth
(Industry Average)
-
(-)
104.97%
(275.10%)
-14.37%
(35.09%)
-19.59%
(-6.09%)
60.73%
(138.39%)
Stability2009-03-312010-03-312011-03-312012-03-312013-03-31
Capital adequacy
(Industry Average)
59.87%
(53.80%)
61.00%
(54.51%)
61.60%
(55.00%)
61.48%
(53.59%)
62.24%
(56.30%)
Liquidity ratio
(Industry Average)
146.59%
(217.72%)
162.64%
(225.70%)
155.95%
(237.55%)
158.62%
(239.89%)
156.32%
(236.21%)
C/F ratio current liabilities
(Industry Average)
485.07%
(777.21%)
246.36%
(303.31%)
322.98%
(434.79%)
432.44%
(929.73%)
296.69%
(573.30%)
Quick ratio
(Industry Average)
95.29%
(138.97%)
111.55%
(148.85%)
105.32%
(156.17%)
105.21%
(160.84%)
104.45%
(156.81%)
Turnover2009-03-312010-03-312011-03-312012-03-312013-03-31
Receivables turnover
(Industry Average)
92.03day
(83.89day)
90.45day
(94.27day)
94.38day
(93.96day)
96.78day
(97.92day)
90.14day
(98.27day)
Inventory turnover
(Industry Average)
47.33day
(54.45day)
49.18day
(52.58day)
51.63day
(52.64day)
54.63day
(56.59day)
54.98day
(58.68day)
Payable turnover
(Industry Average)
27.66day
(45.01day)
27.94day
(49.82day)
28.83day
(49.52day)
31.93day
(52.10day)
28.68day
(51.12day)
Working capita turnover
(Industry Average)
111.70day
(93.32day)
111.69day
(97.02day)
117.18day
(97.08day)
119.48day
(102.41day)
116.44day
(105.83day)
Stock etc.2009-03-312010-03-312011-03-312012-03-312013-03-31
Market Value growth
(Industry Average)
-
(-)
14.69%
(34.57%)
-13.98%
(1.49%)
16.82%
(-3.85%)
24.83%
(21.16%)
Dividend Yield
(Industry Average)
1.32%
(3.20%)
1.35%
(1.93%)
1.57%
(2.17%)
1.54%
(2.45%)
1.23%
(2.07%)
PER
(Industry Average)
17.24%
(25.22%)
15.63%
(23.06%)
13.11%
(16.22%)
14.91%
(29.19%)
18.83%
(16.58%)
PBR
(Industry Average)
1.57%
(0.86%)
1.64%
(1.06%)
1.34%
(1.04%)
1.45%
(0.95%)
1.62%
(1.08%)
PCFR
(Industry Average)
14.37%
(7.18%)
8.04%
(9.23%)
8.08%
(-2.43%)
11.74%
(9.50%)
9.12%
(7.56%)
PSR
(Industry Average)
0.95%
(0.77%)
1.07%
(0.88%)
0.90%
(1.10%)
1.01%
(0.90%)
1.17%
(1.01%)

Financial Indicator Details: ROHTO PHARMACEUTICAL

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Profitability
Net profit margin5.55%6.84%6.89%6.80%6.26%
C/F margin6.65%13.30%11.19%8.63%12.93%
ROA5.47%6.43%6.29%6.01%5.36%
ROE9.14%10.54%10.22%9.78%8.62%
Recurring margin10.26%11.25%11.51%11.37%11.40%
EBIT margin8.69%11.20%11.88%11.81%10.59%
EBITDA margin12.58%15.20%15.57%15.88%14.66%
NOPAT margin5.21%6.72%7.13%7.09%6.35%
Sales SG rates41.04%41.12%40.98%41.50%40.87%
Sales SG&A rates48.42%47.81%47.48%47.27%47.61%
Sales R&D expenses rates3.37%3.29%3.20%3.08%3.14%
Sales depreciation rates3.89%4.00%3.68%4.06%4.06%
Capital expenditures net sales ratio-5.42%-3.63%-7.32%-6.87%-3.97%
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Growth
Growth rate of cash-117.41%5.48%9.03%29.17%
Equity growth-9.76%5.75%7.33%12.13%
Total assets growth-7.74%4.72%7.54%10.76%
Sales growth-2.54%1.80%4.17%7.36%
Net profit growth-26.53%2.54%2.73%-1.18%
Operating C/F growth-104.97%-14.37%-19.59%60.73%
Recurring profit growth-12.52%4.09%2.94%7.64%
EBIT growth-32.06%7.98%3.59%-3.75%
EBITDA growth-23.87%4.23%6.26%-0.87%
NOPAT growth-32.06%7.98%3.59%-3.75%
Operating expenses growth-----
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Stability
Capital adequacy59.87%61.00%61.60%61.48%62.24%
Liquidity ratio146.59%162.64%155.95%158.62%156.32%
C/F ratio current liabilities485.07%246.36%322.98%432.44%296.69%
Quick ratio95.29%111.55%105.32%105.21%104.45%
Fixed ratio53.11%47.87%50.60%50.97%47.73%
D/E ratio13.30%11.05%7.59%10.09%7.66%
Loan to Value Ratio7.96%6.74%4.67%6.20%4.77%
Business investment C/F ratio-81.42%-27.29%-65.47%-79.64%-30.71%
Liabilities with interest growth--8.76%-27.40%42.65%-14.80%
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Turnover
Cash turnover20.29day43.03day44.58day46.67day56.15day
Receivables turnover92.03day90.45day94.38day96.78day90.14day
Inventory turnover47.33day49.18day51.63day54.63day54.98day
Fixed assets turnover117.63day113.49day124.62day129.34day126.49day
Total asset turnover369.86day388.62day399.77day412.68day425.75day
Payable turnover27.66day27.94day28.83day31.93day28.68day
Capital turnover21.11day20.58day20.22day19.43day18.11day
Equity turnover221.47day237.06day246.27day253.74day265.02day
Working capita turnover111.70day111.69day117.18day119.48day116.44day
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Balance sheet
Cash etc.¥ 6 B¥ 13 B¥ 14 B¥ 15 B¥ 19 B
Accounts receivable-trade¥ 27 B¥ 28 B¥ 29 B¥ 31 B¥ 31 B
Other Current Assets¥ 46 B¥ 47 B¥ 50 B¥ 55 B¥ 57 B
Current Assets¥ 52 B¥ 60 B¥ 65 B¥ 71 B¥ 77 B
Tangible Assets¥ 35 B¥ 35 B¥ 39 B¥ 42 B¥ 44 B
Intangible Assets¥ 3 B¥ 2 B¥ 2 B¥ 2 B¥ 2 B
Investment etc.¥ 20 B¥ 22 B¥ 19 B¥ 19 B¥ 26 B
Total Assets¥ 112 B¥ 120 B¥ 126 B¥ 136 B¥ 150 B
Current Liabilities¥ 35 B¥ 37 B¥ 41 B¥ 44 B¥ 49 B
Fixed Liabilities¥ 9 B¥ 9 B¥ 6 B¥ 7 B¥ 7 B
Liabilities with interest¥ 8 B¥ 8 B¥ 5 B¥ 8 B¥ 7 B
Net Assets¥ 67 B¥ 73 B¥ 77 B¥ 83 B¥ 93 B
Capital stock¥ 6 B¥ 6 B¥ 6 B¥ 6 B¥ 6 B
Capital surplus etc.¥ 60 B¥ 67 B¥ 71 B¥ 77 B¥ 87 B
Liabilities and net assets¥ 112 B¥ 120 B¥ 126 B¥ 136 B¥ 150 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Income statement
Sales¥ 110 B¥ 113 B¥ 115 B¥ 120 B¥ 129 B
Cost of Sales¥ 45 B¥ 46 B¥ 47 B¥ 49 B¥ 52 B
Gross profit¥ 65 B¥ 66 B¥ 68 B¥ 70 B¥ 76 B
Other income¥ 676 M¥ 845 M¥ 1 B¥ 1 B¥ 1 B
SG&A¥ 53 B¥ 54 B¥ 54 B¥ 56 B¥ 61 B
Other expenses¥ 6 B¥ 5 B¥ 6 B¥ 6 B¥ 7 B
Net income¥ 6 B¥ 7 B¥ 7 B¥ 8 B¥ 8 B
Operating income¥ 11 B¥ 12 B¥ 13 B¥ 13 B¥ 14 B
Ordinary Income¥ 11 B¥ 12 B¥ 13 B¥ 13 B¥ 14 B
EBITDA¥ 13 B¥ 17 B¥ 17 B¥ 19 B¥ 18 B
Income before income taxes¥ 9 B¥ 12 B¥ 13 B¥ 14 B¥ 13 B
Depreciation¥ 4 B¥ 4 B¥ 4 B¥ 4 B¥ 5 B
R&D expenses¥ 3 B¥ 3 B¥ 3 B¥ 3 B¥ 4 B
Income taxes¥ 3 B¥ 4 B¥ 5 B¥ 5 B¥ 5 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash flow statement
Operating CF¥ 7 B¥ 15 B¥ 12 B¥ 10 B¥ 16 B
Investment CF¥ -8 B¥ -5 B¥ -8 B¥ -9 B¥ -10 B
Financial CF¥ -1 B¥ -1 B¥ -3 B¥ 800 M¥ -3 B
Foreign Exchange Effects¥ -651 M¥ -216 M¥ -303 M¥ -210 M¥ 1 B
Net Change in Cash¥ -3 B¥ 7 B¥ 732 M¥ 1 B¥ 4 B
Free CF¥ -1 B¥ 9 B¥ 4 B¥ 786 M¥ 6 B
Capital expenditures¥ -5 B¥ -4 B¥ -8 B¥ -8 B¥ -5 B
Cash dividends paid¥ -1 B¥ -1 B¥ -1 B¥ -1 B¥ -1 B
Repayment loans¥ -753 M¥ -1 B¥ -2 B¥ -1 B¥ -2 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Shareowners' equity
Issuance of new shares¥ 10 M--¥ 14 M¥ 6 M
Dividends from surplus¥ -1 B¥ -1 B¥ -1 B¥ -1 B¥ -1 B
Net income¥ 6 B¥ 7 B¥ 7 B¥ 8 B¥ 8 B
Purchase of treasury stock¥ -31 M¥ -26 M¥ -7 M¥ -1 M¥ -2 M
Other Change in Stockholders Equity¥ 725 M¥ 5 M¥ -1 M¥ -2 M¥ -344 M
Other Change in Net Assets¥ -2 B¥ 454 M¥ -2 B¥ -599 M¥ 4 B
Net Change in Net Assets¥ 3 B¥ 6 B¥ 4 B¥ 5 B¥ 10 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link


Ticker Market Industry Month report Rating
@ ROHTO PHARMACEUTICAL 4527 TSE 1st Chemicals 3 Annual BB

Related Company

@ 千寿製薬 (Sales ¥ 28 B) +
@ キョーリン製薬ホールディングス (Sales ¥ 107 B) +
@ NIPPON KAYAKU (Sales ¥ 128 B) +
@ 持田製薬 (Sales ¥ 89 B) +
@ SAWAI PHARMACEUTICAL (Sales ¥ 80 B) +
@ ROHTO PHARMACEUTICAL (Sales ¥ 129 B) +
@ Hitachi Chemical (Sales ¥ 464 B) +
@ Nissan Chemical Industries (Sales ¥ 153 B) +
@ Nichi-Iko Pharmaceutical (Sales ¥ 93 B) +
@ Aica Kogyo (Sales ¥ 101 B) +
@ ダイセル (Sales ¥ 358 B) +
@ Kuraray (Sales ¥ 369 B) +
@ アステラス製薬 (Sales ¥ 1.0 T) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.104 sec.)